References
- 1. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation myocardial infarction in Europe: description of the situation in 30 countries. Eur Heart J. 2010;31:943-957. doi: 10.1093/eurheartj/ehp492.10.1093/eurheartj/ehp492
- 2. Schröder R. Prognostic Impact of Early ST segment Resolution in Acute Myocardial Infarction. Circulation. 2004;110:e506-e510. doi: 10.1161/01.CIR.0000147778.05979.E6.10.1161/01.CIR.0000147778.05979.E6
- 3. McLaughlin MG, Stone GW, Amyong E, et al. Prognostic utility of comparative methods for assessment of ST segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004;44:1215-1223. doi: 10.1016/j.jacc.2004.06.053.10.1016/j.jacc.2004.06.053
- 4. de Lemos JA, Braunwald E. ST segment Resolution as a Tool for Assessing the Efficacy of Reperfusion Therapy. J Am Coll Cardiol. 2001;38:1283-1294.10.1016/S0735-1097(01)01550-9
- 5. Schröder R, Weigscheider R, Schröder K, et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol. 1995;26:1657-1664.10.1016/0735-1097(95)00372-X
- 6. Mauri F, Maggioni AP, Franzosi MG, et al. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza ell’Infarto Miocardico (GISSI-2) – Derived Analysis. J Am Coll Cardiol. 1994;24:600-607.10.1016/0735-1097(94)90003-5
- 7. McLaughlin MG, Stone GW, Amyong E, et al. Prognostic Utility of Comparative Methods for Assessment of ST segment Resolution After Primary Angioplasty for Acute Myocardial Infarction – The CADILLAC trial. J Am Coll Cardiol. 2004 Sep 15;44:1215-1223. doi: 10.1016/j.jacc.2004.06.053.10.1016/j.jacc.2004.06.053
- 8. Bename H, Taffet M, Bataille S, et al. Female gender still an independent predictor of in-hospital mortality after STEMI in the era of primary PCI? Insights from the Greater Paris Area PCI Registry. EuroIntervention. 2011;6(9):1073-9. doi: 10.4244/EIJV6I9A187.10.4244/EIJV6I9A187
- 9. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: A systematic overview. Lancet. 2000;355(9206):773-778. doi: 10.1016/S0140-6736(99)08415-9.10.1016/S0140-6736(99)08415-9
- 10. Hsu PH, Jou YL, Lin PL, et al. Comparison of In-hospital outcome of Acute ST. Acta Cardiol Sin. 2011;27:145-151.
- 11. Kosuge M, Kimura K, Kojima S, et al. Impact of body mass index on in hospital outcome after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008;72:521-525.10.1253/circj.72.52118362419
- 12. Wienbergen H. Gih AK, Juenger C, et al. Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clinical Research in Cardiology. 2008;97:83-88. doi: 10.1007/s00392-007-0585-x.10.1007/s00392-007-0585-x17938850
- 13. Payvar SP, Kim S, Rao E, et al. In hospital outcomes of percutaneous coronary interventions in extremely obese and normal weight patients. J Am Coll Cardiol. 2013;62:692-696. doi: 10.1016/j.jacc.2013.05.058.10.1016/j.jacc.2013.05.05823948513
- 14. Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST segment elevation myorcardial infarction, results from the NCDR (National Cardiovascular Registry). J Am Coll Cardiol. 2011;58:2642-50. doi: 10.1016/j.jacc.2011.09.030.10.1016/j.jacc.2011.09.030352332322152950
- 15. Wang W, Chen QF, Yin RX, et al. Clinical features, risk factors, and treatment experience: a review of 74 patients with ST segment elevation myocardial infarction complicated by ventricular fibrillation. J Emerg Med. 2014;47:729-735. doi: 10.1016/j.jemermed.2014.06.041.10.1016/j.jemermed.2014.06.04125278138
- 16. Kang DG, Jeong MH, Ahn Y, et al. Clinical effects of hypertension on mortality of patients with acute myocardial infarction. J Korean Med Sci. 2009;24:800-806. doi: 10.3346/jkms.2009.24.5.800.10.3346/jkms.2009.24.5.800275275919794974
- 17. Abtahian F, Olenchock B, Ou FS, et al. Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry). Am J Cardiol. 2011;107:1441-6. doi: 10.1016/j.amjcard.2011.01.020.10.1016/j.amjcard.2011.01.020374341621420059
- 18. Przylusk J, Kalinczuk L, Kruk M, et al. Early risk stratification in patients treated with primary PCI for STEMI based on simultaneous assessment of admission WBC count and levels of glycemia and creatinine. Circulation. 2006;114(Suppl18)
- 19. Lipšic E, van der Horst ICC, Voors AA, et al. Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol. 2005;100:289-292.10.1016/j.ijcard.2004.10.04315823637
- 20. Shiraishi J, Kohno Y, Sawada T, et al. Prognostic impact of systolic blood pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction. J Cardiol. 2012;60:139-144. doi: 10.1016/j.jjcc.2012.02.008.10.1016/j.jjcc.2012.02.00822521431